Receive The Newest Study Notifications

CStone Pharmaceuticals ("CStone") today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven gastrointestinal...

Outstanding results from SCOPE 1 randomized, controlled, multicentric clinical trial, proving the efficacy of treating life-threatening Abdominal Aortic Aneurysm (AAA), by thrombogenic fibers embolization of the aneurysm sac when performing an EndoVascular Aneurysm...

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular...

Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company, today announced that the U.S. Food & Drug Administration ("FDA")indicated that the Phase 2 clinical study of LPCN 1144 in non-alcoholic steatohepatitis ("NASH") with biopsy confirmed NASH subjects...

Safety lead-in completed, no overlapping toxicities, combination is safe and well tolerated Expanding trial to include alternate dosing schedule to maximize observed clinical activity Trovagene, Inc. (Nasdaq:  TROV), a clinical-stage oncology therapeutics company,...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that it has initiated dosing patients with chronic kidney disease (“CKD”) in a Phase Ib clinical study evaluating DM199. The Phase 1b study, conducted in the US, is a...

Medality Medical LLC, a U.S.-based medical technology company, announced that it has received U.S. Food & Drug Administration (FDA) Investigational Device Exemption (IDE) approval to undertake a clinical trial of its patented proprietary medical device and...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announced that the...

Study follows passage of HOPE Act of 2013, allowing people with HIV to become organ donors The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States. The HOPE in Action...

Advaxis, Inc.  (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announced it has initiated its Phase 1/2 clinical trial to evaluate ADXS-503, part of the Company’s ADXS-HOT...

TrialAssure—a global software company focused on developing clinical trial transparency tools—announced a program called TrialAssure Academic Pricing (TAP) to assist universities globally through managing and disclosing all clinical trial results in a cost-efficient...

Source: Tyme Technologies, Inc. SM-88 therapy did not exhibit typical side effects associated with hormonal castration from androgen-deprivation therapy (ADT) 87% of patients (20/23) remained free of radiographic progression After 12 weeks, all patients had a decrease...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that it has initiated dosing patients with chronic kidney disease (“CKD”) in a Phase Ib clinical study evaluating DM199. The Phase 1b study, conducted in the US, is a...

As a longtime pathologist at the University of Kentucky, Dr. Charles Lutz is no stranger to cancer. Lutz has spent much of his career in the lab, helping patients behind the scenes. At the UK Markey Cancer Center, he works in molecular diagnosis and HLA tissue typing...

Renowned Neurologist Dr. Serge Gauthier to Serve as Site’s Lead Investigator  IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that, subject to final research ethics board approval, Montreal’s Douglas Mental...

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Running a seamless clinical trial means improving not only data quality but also operational logistics and most...

Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials. This collaboration...

Soterix Medical Inc. has been awarded a Phase I NIH-SBIR contract from the National Institute of Drug Abuse (NIDA) of the National Institutes of Health (NIH) for the development of its portable remote-tDCS platform for the treatment of cocaine addiction. Soterix...

Study designed to evaluate safety and tolerability of a novel peptide-based immunotherapy to treat peanut allergies Aravax, a clinical stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy, will present...

MPN-RC sponsored, NIH-supported Phase 1/2 trial in myelofibrosis to commence imminently TGF-beta is a central driver of bone marrow fibrosis in myelofibrosis AVID200 selectively inhibits TGF-beta 1 & 3, the principal fibrotic TGF-beta isoforms, while sparing...